Peptide compound
Cagrilintide
Long-acting amylin analog for satiety and metabolic research.
— Tracked fulfillment · COA included · Discreet packaging
COA · IncludedPurity
>99%
Form
Lyophilized
Storage
-20°C
Grade
Research
— Overview
Cagrilintide at a glance.
Cagrilintide is a long-acting amylin analog studied in metabolic-regulation models, often in combination with GLP-1 receptor agonists. Research focuses on satiety signaling, gastric emptying, and combined incretin-amylin effects on body composition.
— From the clinic
Peptides aren't a substitute for the protocol around them. We design dose, cycle, and stack against your labs and your goals — not a generic vial in a drawer.
Pairs well with
Common stack partners.
peptide solutions
GLP-1
GLP-1 receptor agonist (semaglutide-class) for satiety research.
peptide solutions
GIP / GLP Dual Agonist
Dual GIP and GLP-1 receptor agonist (tirzepatide-class).
peptide solutions
GLP / GIP / Glucagon Triple Agonist
Triple-receptor agonist (retatrutide-class) for advanced metabolic research.
— Want supervision?
Pair Cagrilintide with a
physician-designed protocol.
Stria Performance and Complete tiers include physician-prescribed peptides with comprehensive labs and quarterly follow-up. Take the assessment to see which fits.